- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.04. | With Vyvgart 'firing' in myasthenia gravis, argenx lays launch plans for next potential autoimmune approval: CEO | ||
| 16.04. | Biogen CEO Viehbacher sees 2023 pay fall to $4M after massive welcome package | ||
| 16.04. | J&J reports strong sales numbers for Tecvayli, bolstering company's multiple myeloma 'stronghold' | ||
| 16.04. | On the heels of pulmonary arterial hypertension drug nod, Merck launches 'Outnumber PAH' campaign | ||
| 16.04. | FDA slams 3 Indian drugmakers in flurry of recent Form 483s | ||
| 15.04. | Pfizer, BioNTech win pause in patent infringement case from rival Moderna | ||
| 15.04. | Novartis touts surrogate endpoint win, nabs priority review for Fabhalta in IgAN | ||
| 15.04. | CSL Behring shuts down filling department, lays off 65 staffers at major Illinois manufacturing site | ||
| 15.04. | Marinus faces share-price collapse, weighs 'cost-saving strategies' after IV seizure med comes up short | ||
| 15.04. | Takedowns of websites peddling fake GLP-1 drugs jump as counterfeiters board weight-loss bandwagon | ||
| 15.04. | Roche eyes earlier treatment nod after Columvi-chemo trial win in 2nd-line lymphoma | ||
| 15.04. | Novavax comes under pressure from activist investor as COVID sales fall short | ||
| 15.04. | Viatris, eyeing a return to growth, taps Moderna, Amgen alum as CCO | ||
| 15.04. | AstraZeneca cries havoc over CKD's hit on economies, environment | ||
| 12.04. | FDA advisers back new endpoint for myeloma approvals, paving way for faster introduction of new drugs | ||
| 12.04. | Lady Gaga's Instagram post about latest Pfizer Nurtec ODT ad earns EU ire: Politico | ||
| 12.04. | Eisai on your hi-fi: Leqembi maker supports creation of Alzheimer's podcast miniseries | ||
| 12.04. | EU regulator finds no link between GLP-1s and suicidal thoughts | ||
| 12.04. | With 9% pay hike, Merck CEO Davis entered $20M compensation club in 2023 | ||
| 12.04. | Shareholders approve AstraZeneca's 2024 pay proposal for CEO Pascal Soriot despite proxy adviser discontent | ||
| 11.04. | 89bio lines up China CDMO to build API plant for commercial production of MASH candidate | ||
| 11.04. | Fujifilm Diosynth blueprints another $1.2B expansion at North Carolina plant where it aims to employ 1,400 | ||
| 11.04. | Castle Biosciences fortifies support of Esophageal Cancer Awareness Month with fundraising, educational collabs | ||
| 11.04. | Regeneron hit with DOJ complaint that it hid 'hundreds of millions' in Eylea credit card processing fees from Medicare | ||
| 11.04. | Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
